Skip to content

Changes in Hormones: Does consuming protein or exercising influence the hormones of healthy adults?

Protein, Exercise, and Insulin Like Growth Factor-1 Response in Healthy Adults: Can the time-course and magnitude of response be altered?

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618001919202
Enrollment
24
Registered
2018-11-26
Start date
2019-01-15
Completion date
2019-03-01
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Hypotheses: We hypothesize that dietary protein and exercise will both independently increase the acute Insulin Like Growth Factor-1 (IGF-1) response, but thereafter, exercise will reduce IGF-1 concentration in the rested, fasted state and the associated binding protein (IGFBP3) will decrease with exercise with and without protein . This study will expand upon the current literature regarding the effects of dietary protein, exercise and the combination thereof on IGF-1 and IGFBP3. The knowledge gained from this study may inform public health messages concerning possible adverse health effects of consuming high amounts of protein, and any ameliorating effects of exercise. Knowledge of the time-course of responses will also aid future research to know when to sample for peak and nadir concentrations.

Interventions

Repeated measures three way randomized cross-over design with three conditions and 24 participants. The three conditions are: exercise only, protein only, and exercise with protein. Participants will be randomly assigned to complete the three interventions in one of six possible orders. Interventions will be conducted at the same time of day, separated by a minimum of one week. Materials: Anthropometric measurement tools (scale, tape measure, bio-electrical impedance device for body compositi

Repeated measures three way randomized cross-over design with three conditions and 24 participants. The three conditions are: exercise only, protein only, and exercise with protein. Participants will be randomly assigned to complete the three interventions in one of six possible orders. Interventions will be conducted at the same time of day, separated by a minimum of one week. Materials: Anthropometric measurement tools (scale, tape measure, bio-electrical impedance device for body composition), cycle ergometer (for VO2 max test and exercise condition), metabolic cart (for VO2 max gas exchange), protein smoothie (for high protein intervention), Low protein high carbohydrate smoothie (for isocaloric placebo), standardized full meal for after all interventions (pizza or allergen free equivalent). Supplement Details: High Protein (30g) Supplement Composition: 30g whey isolate protein powder mixed with 30g of carbohydrate in the form of 8 oz almond milk (2g CHO), 1 banana (23g CHO), 8g chocolate syrup (5g CHO) all blended together to form a chocolate banana smoothie with approximately 1004 kJoules of energy. Low Protein (0g) Supplement Composition: 60g of carbohydrates in the form of 8 oz almond milk (2g CHO), 1 banana (23g CHO), 53g chocolate syrup (35g CHO) all blended together to form a chocolate banana smoothie with approximately 1004 kJoules of energy. Procedures: Initial Testing Session After providing written informed consent, and at least one week prior to participating in the first intervention session, anthropometric measurements and bio-electrical impedance analysis for body composition will be conducted. A maximal oxygen capacity (VO2max) test will then be conducted on a cycle ergometer to determine training status of the participants. This will take approximately 12-15 min, in which intensity is increased in a graded fashion while respiratory gas analysis is conducted. The test will be administered by a trained exercise physiologist (Colleen Gulick). Participants will also fill out a Physical Activity Readiness Questionnaire (PAR-Q) to assess suitability to perform maximal exercise and reduce risk. An exercise history questionnaire will also be completed to determine the amount of exercise they have been performing in the previous three months. Protein Trial Participants will report to the testing facility at 6:30 am after a 10-hour overnight fast. The researcher will confirm that the participant did not exercise for the past 24 hours. After these confirmations the participant will remain seated until 6:45 am, at which point the baseline blood samples will be drawn. The participant will remain seated until 7:30am. Between 7:30 and 7:35am the participant will consume a single dose of a high protein meal. The protein meal will be comprised of 30 g of protein and 30 g of carbohydrate (whey isolate protein powder mixed with fruit smoothie base for taste) totaling 1004 kJoules. A post-intervention blood draw will occur at 7:35 am. From 7:35 am to 10 am the participant will remain seated at the testing site and blood measurements will be conducted every 30 minutes. After 2.5 hours the blood draws will be reduced to one 5mL draw per hour. Participants will be asked to refrain from performing any exercise or eating until the final blood draw of the day (14:00). At 14:05 the participants will be provided with a standardized meal consisting of frozen pizza (or allergen-free equivalent). The following morning the participant will report back to the testing facility and provide a blood sample (via venipuncture) at 7:00 am to see when/if the IGF-1 and IGFBP3 concentrations return to normal after the trial. Exercise Trial The protocol will be the same as described in “Protein Intervention” however, no protein will be consumed between 7:30 am and 7:35 am. Instead, at 7:05 am the participant will perform a 20-minute exercise protocol based on the results of their initial testing session. The exercise will consist of four cycles of: 4 minutes at 15% of aerobic threshold power followed by 30 seconds of maximum effort. The session will end with 2 minutes at 15% aerobic threshold power. Participants will be given an iso-caloric placebo meal consisting of 0 g protein and 60 g of carbohydrate (fruit smoothie) at 7:30 am. In this way the caloric intake will be controlled between all trials and any affects will be a result of protein ingestion. Exercise and Protein Trial The protocol will be the same as described in “Protein Intervention” however, exercise will be conducted between 7:05 am and 7:30 am before consumption of the single high protein (30 g) supplement between 7:30 am and 7:35 am. Supplement Details: High Protein (30g) Supplement Composition: 30g whey isolate protein powder mixed with 30g of carbohydrate in the form of 8 oz almond milk (2g CHO), 1 banana (23g CHO), 8g chocolate syrup (5g CHO) all blended together to form a chocolate banana smoothie with approximately 1004 kJoules of energy. Who: Exercise physiologist (to deliver intervention) & research nurse (perform cannulation) Mode of Delivery: face to face delivery. Interventions may be conducted as a group if scheduling permits but each participant will adhere to their own individualized and randomized intervention. Number of Times: 3 sessions (once per week) Duration: 7 hours each session Location: University of Otago, Dunedin, New Zealand

Sponsors

Assoc Prof Nancy Rehrer
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

To be included in the study participants will: • have a BMI < 35 • be physically capable of participating in physical activity as indicated by Physical Activity Readiness Questionnaire score that indicates maximal exercise ill advised • be aged between 18 and 65 y • speak and understand English

Exclusion criteria

- not be on any medication (besides birth control pills, vitamins/ minerals) - not have Diabetes, cardiovascular disease or other known or identifiable disease state, disease - not be pregnant or planning a pregnancy - not be lactose intolerant

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026